Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11676
Owlet
OWLT
$146M
| $79.5K | ﹤0.01% |
21,602
-9,600
| -31% | -$43.5K |
|
|
EMX
11677
DELISTED
EMX Royalty
EMX
| $79.3K | ﹤0.01% |
38,883
+5,141
| +15% | +$9.3K |
|
|
EEX
11678
DELISTED
Emerald Holding
EEX
| $79.3K | ﹤0.01% |
20,169
-59,011
| -75% | -$255K |
|
|
GIFT
11679
Giftify Inc
GIFT
$28.9M
| $79.2K | ﹤0.01% |
+39,584
| New | +$57.2K |
|
|
BRFS
11680
DELISTED
BRF SA
BRFS
| $78.9K | ﹤0.01% |
22,943
-4,399
| -16% | -$15.5K |
|
|
MITT
11681
PUT
TPG Mortgage Investment Trust
MITT
$212M
| $78.8K | ﹤0.01% |
10,800
-200
| -2% | -$1.42K |
|
11682
PUT
Clarus
CLAR
$144M
| $78.8K | ﹤0.01% |
21,000
-9,700
| -32% | -$43.5K |
|
|
FIRY
11683
PUT
Firy Inc
FIRY
$167M
| $78.8K | ﹤0.01% |
17,500
+2,000
| +13% | +$11.4K |
|
11684
Amtech Systems
ASYS
$277M
| $78.5K | ﹤0.01% |
+16,260
| New | +$83.9K |
|
11685
CALL
Sensus Healthcare
SRTS
$55.5M
| $78.5K | ﹤0.01% |
16,600
-10,800
| -39% | -$62.9K |
|
|
PVL
11686
Permianville Royalty Trust
PVL
$60.1M
| $78.5K | ﹤0.01% |
50,157
-40,268
| -45% | -$59.7K |
|
11687
CALL
Alta Equipment Group
ALTG
$202M
| $78.3K | ﹤0.01% |
16,700
-1,500
| -8% | -$9.36K |
|
|
RPT
11688
PUT
Rithm Property Trust
RPT
$102M
| $77.8K | ﹤0.01% |
4,517
-850
| -16% | -$15.4K |
|
11689
CALL
nLIGHT
LASR
$2.6B
| $77.7K | ﹤0.01% |
+10,000
| New | +$101K |
|
|
ICAD
11690
PUT
DELISTED
iCAD Inc
ICAD
| $77.7K | ﹤0.01% |
37,700
+12,500
| +50% | +$31.8K |
|
|
YSG
11691
CALL
Yatsen Holding
YSG
$283M
| $77.4K | ﹤0.01% |
+16,100
| New | +$63K |
|
11692
China Automotive Systems
CAAS
$152M
| $77.4K | ﹤0.01% |
17,516
-11,321
| -39% | -$48.7K |
|
11693
Telomir Pharmaceuticals
TELO
$81.8M
| $76.5K | ﹤0.01% |
+23,699
| New | +$104K |
|
|
CNSY
11694
Cerenome
CNSY
$23.5M
| $76.5K | ﹤0.01% |
+3,220
| New | +$90K |
|
11695
PUT
Rackspace Technology
RXT
$861M
| $76.2K | ﹤0.01% |
45,100
+4,200
| +10% | +$10K |
|
11696
ALX Oncology
ALXO
$283M
| $75.8K | ﹤0.01% |
121,710
-29,910
| -20% | -$35.9K |
|
11697
PUT
Stem
STEM
$54.9M
| $75.8K | ﹤0.01% |
10,825
+6,795
| +169% | +$78.7K |
|
|
EB
11698
PUT
DELISTED
Eventbrite
EB
| $75.7K | ﹤0.01% |
35,900
-28,100
| -44% | -$84.4K |
|
11699
PUT
Galectin Therapeutics
GALT
$418M
| $75.6K | ﹤0.01% |
62,000
-388,200
| -86% | -$545K |
|
11700
PUT
Mama's Creations
MAMA
$745M
| $75.5K | ﹤0.01% |
11,600
-15,900
| -58% | -$110K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.